Brunei Health Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Brunei Health Wire.

Press releases published on July 27, 2026

Jul. 27, 2026

Landmark 10-Year Study Strengthens Long-Term Evidence Supporting Focal Therapy

Indeterminate GlobeNewswire

Jul. 27, 2026

10 年里程碑式研究，为局灶治疗长期疗效提供有力证据

Indeterminate GlobeNewswire

Jul. 27, 2026

Revagenix Doses First Participant in Phase 1 Trial of Rev-56, an Inhaled Therapy for Non-CF Bronchiectasis

Indeterminate GlobeNewswire

Jul. 27, 2026

Parexel Recognized as a World’s Top Disability Inclusive Business by the Disability Index® from Disability:IN

Indeterminate GlobeNewswire

Jul. 27, 2026

HealthEx Launches HealthEx Wallet, a Secure App for Individuals to Access, Understand, and Manage Their Health Records

Indeterminate GlobeNewswire

Jul. 27, 2026

HealthEx to Help Americans Bring Their Medical Records into AskMD by Sharecare

Indeterminate GlobeNewswire

Jul. 27, 2026

Vadma Institute Expands Global Practitioner Certification Program as Interest Grows in Its Neuro-Somatic Wellness Method

Indeterminate GlobeNewswire

Jul. 27, 2026

Cato Healthcare Supply Appoints Ryan F. Zackon as President and Chief Executive Officer

Indeterminate GlobeNewswire

Jul. 27, 2026

Flourish Health Raises $46M to Scale Intensive Mental Health Care for Youth in Crisis

Indeterminate GlobeNewswire

Jul. 27, 2026

Lexicon Pharmaceuticals Completes Enrollment of Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Non-Obstructive and Obstructive Hypertrophic Cardiomyopathy (HCM)

Indeterminate GlobeNewswire

Jul. 27, 2026

Cristcot Presents Poster and Select Oral Presentation for Implementing Endocrine Principles to Assess Safety and Compliance within a Clinical Trial at ENDO 2026

Indeterminate GlobeNewswire

Jul. 27, 2026

Vivos Inc. (OTCQB: RDGL) Reports Second Quarter 2026 Progress and Corporate Update

Indeterminate GlobeNewswire

Jul. 27, 2026

Entera Bio Announces Pricing of Oversubscribed $275 Million Private Placement

Indeterminate GlobeNewswire

Jul. 27, 2026

NewGen to Acquire Additional 3% of K25.ai at US$250 Million Valuation Following Strong Community Beta; Strengthening Market Cap Above US$5 Million

Indeterminate GlobeNewswire

Jul. 27, 2026

SciSparc Announces Decision to Target the Agentic AI Market; Forms Scientific Advisory Board for Artificial Intelligence and Cybersecurity

Indeterminate GlobeNewswire

Jul. 27, 2026

Medicus Pharma Receives FDA “Study May Proceed” Letter for NDA-Enabling Registrational SkinJect® Study in Patients with Gorlin Syndrome

Indeterminate GlobeNewswire

Jul. 27, 2026

Veru Announces Full Enrollment for Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss

Indeterminate GlobeNewswire

Jul. 27, 2026

Pluristyx Partners With Leading Regenerative Medicine and Aerospace Pioneers to Standardize Clinical-Grade Hepatocyte Manufacturing for Space and Earth Applications

Indeterminate GlobeNewswire

Jul. 27, 2026

CytomX Therapeutics Announces Appointment of Charles Fuchs, M.D., M.P.H., to the Board of Directors

Indeterminate GlobeNewswire

Jul. 27, 2026

Sofwave to Participate in 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

Indeterminate GlobeNewswire